COMMON STOCK PURCHASE WARRANT OPGEN, INC.Opgen Inc • March 9th, 2021 • Services-medical laboratories • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [_________________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after March 9, 2021 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on March 9, 2026 (the “Termination Date”), but not thereafter, to subscribe for and purchase from OpGen, Inc., a Delaware corporation (the “Company”), up to [______] shares of common stock, par value $0.01 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). This Warrant was issued pursuant to Section 2.2 of that certain Warrant Exercise Agreement, dated as of March 9, 2021 (the “Agreement Date”), by and between the Company and the Holder (as may be amended, amended and restated, supplemented or otherwise modified from time to time in accordance with its terms, the “Warrant Exercise Agre
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • March 9th, 2021 • Opgen Inc • Services-medical laboratories
This Warrant Exercise Agreement (this “Agreement”), dated as of March 9, 2021, is by and between OpGen, Inc., a Delaware corporation (the “Company”), and the undersigned holders (the “Holder”) of warrants to purchase shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”).
